GLAXF Dividend: GSK plc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

GLAXF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	32,166	31,376	30,328	29,324	24,696	24,354
Revenue Growth (YoY)	3%	3%	3%	19%	1%	-28%
Cost of Revenue	8,839	8,817	8,363	8,467	8,006	7,321
Gross Profit	23,327	22,559	21,965	20,857	16,690	17,033
Selling, General & Admin	9,014	8,974	9,029	8,128	6,749	7,025
Research & Development	6,272	6,023	5,750	5,062	4,525	4,322
Operating Expenses	14,900	14,422	13,661	12,462	10,941	11,039
Other Non Operating Income (Expenses)	--	218	-48	-799	561	-409
Pretax Income	7,014	3,477	6,064	5,628	3,599	5,170
Income Tax Expense	951	526	756	707	83	67
Net Income	5,494	2,575	4,928	14,956	4,385	5,749
Net Income Growth	119%	-48%	-67%	241%	-24%	24%
Shares Outstanding (Diluted)	4,102	4,142	4,111	4,084	4,052	4,030
Shares Change (YoY)	1%	1%	1%	1%	1%	0%
EPS (Diluted)	1.33	0.62	1.19	3.66	1.08	1.42
EPS Growth	119%	-48%	-67%	239%	-24%	23%
Free Cash Flow	4,697	3,572	4,424	5,145	5,021	6,202
Free Cash Flow Per Share	1.14	0.86	1.07	1.25	1.23	1.53
Gross Margin	72.52%	71.89%	72.42%	71.12%	67.58%	69.93%
Operating Margin	26.19%	25.93%	27.38%	28.62%	23.27%	24.61%
Profit Margin	17.08%	8.2%	16.24%	51%	17.75%	23.6%
Free Cash Flow Margin	14.6%	11.38%	14.58%	17.54%	20.33%	25.46%
EBITDA	8,507	8,192	8,376	8,486	5,850	6,069
EBITDA Margin	26.44%	26.1%	27.61%	28.93%	23.68%	24.91%
D&A For EBITDA	80	55	72	91	101	75
EBIT	8,427	8,137	8,304	8,395	5,749	5,994
EBIT Margin	26.19%	25.93%	27.38%	28.62%	23.27%	24.61%
Effective Tax Rate	13.55%	15.12%	12.46%	12.56%	2.3%	1.29%